Interferon: The Dawn of Recombinant Protein Drugs: 5 (Schering Foundation Symposium Proceedings Supplements) - Tapa blanda

 
9783662037898: Interferon: The Dawn of Recombinant Protein Drugs: 5 (Schering Foundation Symposium Proceedings Supplements)
Tapa blanda
ISBN 10: 3662037890 ISBN 13: 9783662037898
Editorial: Springer, 2013

Sinopsis

The publication ot the discovery of interferon by Issaacs and Lindenmann in 1957 was not only a milestone in the fields of virology, immunology and infectious diseases but also provided the seed for the growth of the biotechnology industry 20 years later. As of today the interferons belong to a small group of bestselling drugs of all times

"Sinopsis" puede pertenecer a otra edición de este libro.

Reseña del editor

Forty years of Interferon I wish to dedicate this short introduction to the memory of Alick Isaacs (1921-1967), and to that of Sir Christopher Andrewes (1896-1988). Let us go back more than 40 years. In 1956 Isaacs was in charge of the Wodd Influenza Centre. Andrewes was head of the division of bac­ teriology and virology, and deputy director of the National Institute for Medical Research in London. When researchers are faced with a seemingly new phenomenon, ex­ planations are easy to come by. These explanations fall into two broad categories: the phenomenon in question is either due to something or to the lack of something. I apologize for the primitive way in which I ex­ press this, but I am going to give three examples, scattered over 100 years, of what I mean. First example: in 1880 the great French microbiologist Louis Pas­ teur was involved in work on chicken cholera. He was struck by the following observation: if a suitable chicken broth was inoculated with the bacterium, the organism grew profusely and the liquid became tur­ bid. If he now freed the fluid, by sedimentation or filtration, from the bulk of the organisms and re-inoculated it with the same bacterium, no growth occurred.

Reseña del editor

This book describes the discovery, the production and the clinical development of interferon, one of the first genetically engineered proteins and one of the most innovative and successful drugs of all time. The authors all played either a key role in this process or are highly reputed historians of science. This volume is a must for everyone who appreciates the enormous cultural and social implications of scientific endeavor.

"Sobre este título" puede pertenecer a otra edición de este libro.

Editorial
Springer
Año de publicación
2013
Idioma
Inglés
ISBN 10 
3662037890
ISBN 13 
9783662037898
Encuadernación
Tapa blanda
Número de páginas
156
Editor
Lindenmann J., Schleuning W.-D.
Contacto del fabricante
GPSR Kontakt
ProductSafety@springernature.com

Tiergartenstr. 17
Heidelberg
69121
Alemania

Otras ediciones populares con el mismo título

9783540661702: Interferon: The Dawn of Recombinant Protein Drugs: v. 5 (Ernst Schering Foundation Symposium Proceedings / Schering Foundation Symposium Proceedings Supplements)

Edición Destacada

ISBN 10:  3540661700 ISBN 13:  9783540661702
Editorial: Springer-Verlag Berlin and Heide..., 1999
Tapa dura